Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial

Publication date: November 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 11Author(s): Megumi Oshima, Brendon L Neuen, Meg J Jardine, George Bakris, Robert Edwards, Adeera Levin, Kenneth W Mahaffey, Bruce Neal, Carol Pollock, Norman Rosenthal, Takashi Wada, David C Wheeler, Vlado Perkovic, Hiddo J L Heerspink
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research